tm
Seeing Is Believing
tm
Seeing Is Believing
SYRE is currently covered by 3 analysts with an average price target of $26.55. This is a potential upside of $9.26 (53.56%) from yesterday's end of day stock price of $17.29.
Spyre Therapeutics's activity chart (see below) currently has 0 price targets and 6 ratings on display. The stock rating distribution of SYRE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 19.5 days.
Highest price target for SYRE is $41, Lowest price target is $16, average price target is $47.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 13-May-2024. First documented stock forecast 18-Dec-2023.
Currently out of the existing stock ratings of SYRE, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$23.03 (135.71%)
$35
1 years 1 months ago
(13-May-2024)
1/2 (50%)
$3 (8.11%)
4
Buy
$54
$37.03 (218.21%)
$27
1 years 2 months 19 days ago
(25-Mar-2024)
1/2 (50%)
$15.52 (40.33%)
35
What is SYRE (Spyre Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SYRE (Spyre Therapeutics) with a proven track record?
Which analyst has the current lower performing score on SYRE (Spyre Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SYRE (Spyre Therapeutics)?
Which analyst is the currently most bullish on SYRE (Spyre Therapeutics)?
Which analyst is the currently most reserved on SYRE (Spyre Therapeutics)?
